GSK's Velzatinib Receives Orphan Drug Designation in Japan for GIST
GSK said Velzatinib obtained orphan drug designation in Japan for treating gastrointestinal stromal tumors.
GSK said Velzatinib obtained orphan drug designation in Japan for treating gastrointestinal stromal tumors.